Phenotypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates
DOI:
https://doi.org/10.18203/2320-6012.ijrms20170148Keywords:
Constitutive clindamycin resistance, D test, Inducible clindamycin resistance, MRSA, Staphylococcus aureusAbstract
Background: Staphylococcus aureus is a leading cause of nosocomial and community acquired infection in every region of world. Clindamycin is a frequent therapeutic option in the treatment of skin and soft tissue infection caused by Staphylococcus aureus. However resistance to this drug is again a problem which may be inducible or constitutive. The present study was carried out to determine the prevalence of inducible clindamycin resistance among Staphylococcus aureus and to find out the relationship between methicillin resistant Staphylococcus aureus and inducible clindamycin resistance.
Methods: A total of 177 Staphylococcus aureus isolated from different clinical samples were subjected to routine antibiotic sensitivity testing by Kirby Bauer disc diffusion method. All were tested for Methicillin resistance by using cefoxitin 30 µg disc. Inducible clindamycin resistance was detected by ‘D’ test as per CLSI guidelines.
Results: Out of the 177 Staphylococcus aureus isolates, 77 (43.50%) were MRSA and 100 (56.50%) were MSSA. 101 (57.06%) isolates were erythromycin resistant. These erythromycin resistant isolates when subjected to ‘D’ test, 27 isolates showed MS phenotype, 26 showed inducible MLSB phenotype and 48 showed constitutive MLSB phenotype. Out of 77 MRSA isolates 23 (29.87%) showed Inducible MLSB phenotype and 33 (42.85%) showed Constitutive MLSB phenotype, while in 100 methicillin sensitive Staphylococcal isolates 03 (3%) showed Inducible MLSB phenotype and 15 (15%) showed Constitutive MLSB phenotype. The percentage of inducible and constitutive resistance was higher amongst MRSA isolates as compared to MSSA isolates.
Conclusions: Study showed that ‘D’ test should be used routinely to detect inducible clindamycin resistance.References
Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I. Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol. 2007;56:342-5.
Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003;41:4740-4.
Sivapalasingam S, Steigbigel NH. Macrolides, clindamycin and ketolides. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett’s Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone. 2005:410-7.
Coyle EA, Lewis RL, Prince RA. Influence of clindamycin on the releas of Staphylococcus aureus a-hemolysin from methicillin resistant S. aureus: could MIC make a difference ? Crit Care Med. 2003;31(Suppl):A48.
Deotale V, Mendiratta DK, Raut U, Narang P. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. Ind J Med Microbiol. 2010;28:124-6.
CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute. 2014.
Baird D. Staphylococcus, Chapter 11, In: Collee JG, Fraser AG, Marmion BP, Simmons A editors. Mackie and Mc Cartney practical medical microbiology 14th ed, New York, Churchill Livingstonne. 1996;245-61.
Mittal V, Kishore S, Siddique ME. Prevalence of inducible clindamycin resistance among clinical isolates of staphylococcus aureus detected by phenotypic method: A Preliminary report. J of infect Diseases and immunity. 2013;5:10-2.
Sasirekha B., Usha MS., Amruta JA, Ankit S, Brinda N, Divya R. Incidence of constitutive and inducible clindamycin resistance among hospital–associated Staphylococcus aureus. 3 Biotech 2014;4:85-9.
Ajantha GS, Kulkarni RD, Shetty J, Sukhada C, Jain P. Phenotypic detection of inducible Clindamycin resistance among S.aureus isolates by using lower limit of recommended inter disk distance. Ind J Pathol Microbiol. 2008;51:376-8.
Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R. Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Ind J Med Res. 2006;123:571-3.
Prabhu K, Rao S, Rao V. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J Lab Phys. 2011;3:25-7.
Schreckenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase negative Staphylococci in a community and a tertiary care hospital. J Clin Microbiol. 2004;42:2777-9.
Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother. 2005;49:1222-4.
